Co-defendants allegedly helped identify and route vulnerable seniors into billed wound-care services
WASHINGTON, DC — Federal prosecutors allege that two Florida registered nurses helped Leigh Tesar locate Medicare beneficiaries with wounds and steer them toward her Sarasota practice, creating a referral pipeline that turned patient access into extraordinarily valuable allograft billing opportunities.
The alleged arrangement placed Walter Presha Junior and Koby Evans between prospective wound-care patients, Tesar Primecare, and an unnamed Pennsylvania distributor, with compensation purportedly increasing based on the invoiced value of products associated with the beneficiaries they referred.
The June 17, 2026, federal indictment charges Tesar, Presha, and Evans with a conspiracy involving Medicare kickbacks, while separately charging Tesar with five health-care fraud counts and two payment offenses involving alleged remuneration.
Prosecutors contend the eighteen-month operation generated more than $118 million in Medicare claims and over $61 million in payments, with high-priced skin substitutes allegedly furnishing the economic engine that made each newly identified wound potentially worth substantial federal reimbursement.
Every accusation involving patient referrals, sham agreements, kickbacks, unnecessary treatment, false documentation, unperformed procedures, concealment, or disputed proceeds remains unproven, and all three defendants retain the presumption of innocence unless valid pleas or trial verdicts establish guilt.
“Patient feeders” describes a theory, not an indictment quotation
The phrase “patient feeders” does not appear in the charging document and should be understood as journalistic shorthand for the prosecution’s allegation that purported sales representatives identified Medicare beneficiaries with wounds and referred them to Tesar for compensation.
That clarification matters because the label can sound more categorical and dehumanizing than the allegations themselves, which describe particular professional relationships, communications, agreements, financial calculations, and bank deposits that prosecutors must still authenticate and prove.
The government calls Presha and Evans purported sales representatives, alleging their real assignment was beneficiary referral rather than conventional product marketing, but neither professional title nor proximity to patients establishes an unlawful bargain without evidence concerning purpose and intent.
Likewise, a clinician who notices a wound, recommends specialist attention, or introduces a patient to another practitioner does not commit a crime merely because subsequent care receives Medicare reimbursement, since lawful coordination is routine within complicated health-care settings.
The criminal theory instead depends upon an alleged exchange in which access to beneficiaries was rewarded through remuneration tied to federally reimbursable allografts, converting otherwise permissible referrals into transactions prosecutors characterize as knowing violations of the Anti-Kickback Statute.
Three nursing professionals occupied different alleged roles
The indictment identified Tesar as a licensed nurse practitioner who enrolled individually with Medicare and later reassigned her program benefits to Primecare, a Florida business registered as a single- or multispecialty clinic or group practice.
Prosecutors identified Presha as a licensed registered nurse and owner of Universal Nursing and Wellness, and also linked him to the fictitious business name W P Enterprises and an account that received the larger charged referral payment.
Evans was identified as a licensed registered nurse and owner of Healing His Way, another Florida company whose bank account allegedly received the smaller charged deposit from the distributor connected with the disputed allograft transactions.
Those credentials may have given Presha and Evans legitimate opportunities to meet people needing wound care, understand clinical terminology, recognize insurance status, communicate with providers, and present introductions as routine coordination rather than compensated patient sourcing.
However, licenses can also complicate the government’s burden because nurses routinely educate patients, coordinate services, communicate with vendors, and refer people for care, requiring prosecutors to distinguish corrupt remuneration from legitimate nursing, outreach, or sales activity.
Purported sales agreements allegedly concealed referrals
Company One, the indictment’s name for an unidentified Pennsylvania business, allegedly marketed and sold wound-care products to Tesar and Primecare while engaging Presha, Evans, and others as purported representatives through its registered fictitious business name.
Prosecutors describe the resulting agreements as sham arrangements because Presha and Evans allegedly did not primarily sell or market allografts independently, but were instead engaged to supply Medicare beneficiaries whose wounds could support expensive applications billed through Primecare.
The distinction between selling a product and sourcing a patient becomes crucial when compensation follows the economic value generated by a referral, especially if payment rises with product price, wound area, application frequency, or the resulting invoice.
A legitimate distributor representative might educate clinicians, manage inventory, explain product characteristics, support ordering, or develop accounts without controlling patient selection, while an unlawful referral arrangement allegedly pays for directing federally insured people toward reimbursable items or services.
The defense may argue that genuine commercial work supported the contracts, that payment reflected lawful services and fair value, or that prosecutors have misunderstood hybrid clinical and sales responsibilities within a developing wound-care business model.
The government, by contrast, can attempt to prove economic substance through agreement language, work records, calendars, training materials, sales activity, patient lists, communications, invoice calculations, bank transfers, and testimony explaining what Presha and Evans actually did before receiving money.
Patient identification carried exceptional financial value
Allografts described in the case included bioengineered skin substitutes made from human placental tissue, which could be applied over open wounds to assist closure or skin growth when coverage, documentation, and medical-necessity requirements were satisfied.
Because some products were billed by the square centimeter, a single referral involving a substantial wound could generate enormous claim value, making measurements, product choice, repeated applications, and recorded wastage financially consequential throughout the alleged operation.
Prosecutors contend Tesar purchased costly products from Company One, applied or claimed to apply them through Primecare, and caused Medicare claims to be submitted after the purported representatives identified beneficiaries who could enter the reimbursement chain.
That structure allegedly made the patient the scarce commercial input connecting distributor inventory with federal payment, even though the beneficiary’s health, prognosis, informed consent, and clinical needs should have remained the central considerations governing treatment.
Responsible reporting should therefore describe the alleged referral economics without reducing beneficiaries to billing units, because the people involved may have faced chronic wounds, infection, disability, terminal illness, limited mobility, or dependence upon trusted health professionals.
Messages allegedly reveal the referral function
The indictment attributes a June 2024 exchange to Tesar in which she discussed going “room to room looking for wounds” before acknowledging possible illegality, language prosecutors may use to connect patient discovery with an awareness that conventional boundaries were being crossed.
No location is identified within that quoted exchange, so the message should not be embellished into a claim that anyone searched a particular nursing home, assisted-living facility, hospital, or residential complex without supporting evidence.
Defense lawyers can examine the conversation’s surrounding messages, tone, audience, completeness, authenticity, and practical context, while arguing that provocative or careless language does not establish an agreement, a paid referral, or a fraudulent Medicare claim.
In September 2024, Tesar allegedly advised Presha that associated invoices totaled approximately $4.07 million and paired that figure with a twenty-percent calculation approaching $813,925, giving prosecutors a numerical illustration of the alleged compensation model.
That calculation may support an inference that Presha’s expected compensation depended upon product value connected with beneficiaries rather than hours worked, independent marketing results, fixed salary, documented expenses, or another conventional measure of legitimate sales services.
In January 2025, prosecutors say Tesar introduced Evans to an owner of Company One while indicating that Evans already had several patients in mind who could begin treatment quickly, allegedly placing beneficiary access at the center of the introduction.
The defense may contend that identifying patients who could benefit from treatment is not synonymous with selling referrals, making the financial terms, subsequent conduct, clinical appropriateness, and relationship between each introduction and each payment essential to the ultimate determination.
Product pricing allegedly increased referral rewards
Later January messages allegedly told Evans that a new allograft cost $2,000 per square centimeter and that his twenty-percent share would be calculated from that amount instead of a product priced at $1,591 per square centimeter.
Tesar allegedly sent Presha a related message describing the higher-priced product and saying his compensation would increase significantly, while also expressing an intention to switch patients toward the new material according to the prosecution’s account.
Those exchanges could help prosecutors argue that financial return influenced product selection, because the anticipated reward for a purported representative would rise automatically when the practice used a more expensive allograft on a referred beneficiary.
Yet price discussions are not inherently criminal in health care, and defense counsel may argue that product quality, availability, reimbursement rules, wound characteristics, purchasing terms, or clinical performance provided legitimate reasons to evaluate a different allograft.
The critical question will be whether admissible evidence proves that treatment decisions and representative payments were linked through referrals, rather than merely showing that participants discussed prices within a business purchasing and distribution relationship.
A concealed payment route allegedly completed the cycle
In April 2025, Tesar allegedly warned Evans that she was not supposed to discuss money with the purported representatives, a statement prosecutors may portray as evidence that participants understood the compensation channel required separation or concealment.
Three months later, Tesar allegedly emailed a Company One owner information matching Primecare payments with specific products, patients, and purported representatives, enabling the distributor to attribute business value and calculate payments associated with Presha and Evans.
That patient-product-representative matching is central to the alleged feeder structure because it purportedly connected each beneficiary source with the invoice generated after Primecare purchased an allograft, creating an auditable route from referral to remuneration.
On August 15, 2025, Company One allegedly deposited approximately $397,570 into the W P Enterprises account associated with Presha and approximately $10,998 into the Healing His Way account associated with Evans during the alleged operation.
Counts seven and eight accuse Tesar of offering and paying remuneration through those transactions, while counts nine and ten accuse Presha and Evans, respectively, of soliciting and receiving the same money in return for Medicare beneficiary referrals.
The conspiracy count reaches a broader alleged agreement extending from May 2024 through November 2025, allowing prosecutors to connect messages, referrals, products, invoices, payments, and concealment beyond the two deposits chosen for substantive charges.
The term “cash” includes account deposits
Although kickbacks are sometimes imagined as envelopes filled with banknotes, the charged transfers were alleged deposits between business accounts, illustrating how disputed remuneration can travel through formal entities, contracts, invoices, and recognizable financial institutions.
The Anti-Kickback Statute can reach remuneration offered or received directly or indirectly, overtly or covertly, in cash or in kind, provided prosecutors establish the required intent and connection with federally reimbursable referrals or services.
Using companies and written agreements does not automatically legitimize a payment, just as receiving money connected with health-care commerce does not automatically prove a kickback, because the economic purpose and participants’ knowledge remain decisive.
Financial investigators can compare deposit dates with patient referrals, product purchases, Medicare submissions, distributor invoices, representative communications, and withdrawals, while examining whether the compensation method changed as scrutiny increased or particular claims were questioned.
The defense can seek evidence of actual marketing work, sales territories, customer development, education, inventory support, ordinary commissions, tax reporting, and comparable arrangements, then challenge whether the government has proven a referral bargain beyond reasonable doubt.
Medicare beneficiaries were not necessarily all seniors
The subtitle’s reference to vulnerable seniors reflects Medicare’s predominantly older population, but the program also covers certain younger people with disabilities or end-stage renal disease, and the indictment does not establish that every beneficiary was elderly.
That distinction prevents an appealing narrative from outrunning the record, while preserving the larger vulnerability issue created when people with serious wounds depend upon licensed professionals to explain options, costs, likely outcomes, and financial obligations.
Some beneficiaries were allegedly terminally ill, according to prosecutors, while others purportedly had infected wounds, wounds responding to conservative treatment, or conditions that did not justify the advanced products submitted for federal reimbursement.
Terminal illness does not make every wound intervention improper, because legitimate palliative treatment can address pain, odor, drainage, bleeding, infection, comfort, and dignity even when complete closure remains unlikely during a patient’s remaining life.
The relevant allegation is that particular expensive allografts were presented as covered healing treatments when clinical circumstances allegedly made them unreasonable, unnecessary, unsuccessful, infected, or incapable of achieving the restorative purpose represented to Medicare.
Patients allegedly received inducements as well
Prosecutors contend the referral pipeline did not end when beneficiaries reached Primecare, because participants allegedly encouraged patients to begin or continue allograft treatment by misstating costs, unlawfully waiving copayments, and supplying valuable items.
The charging document identifies free medical supplies, jewelry, and a leather recliner as alleged inducements, vivid details that prosecutors may use to show how financial resistance or patient hesitation was purportedly overcome during repeated treatment.
Copayments can give beneficiaries a personal financial stake in utilization, so routine undisclosed waivers may attract enforcement attention when they allegedly remove resistance to products that generate reimbursement far greater than what the patient sees.
However, not every hardship accommodation, charitable gesture, free supply, or convenience constitutes illegal remuneration, and the government must establish who offered each benefit, its value, its purpose, and its relationship to federally reimbursable treatment.
Beneficiaries should not be portrayed as knowing conspirators merely because they accepted care or assistance, since the indictment principally presents them as treatment recipients whose Medicare eligibility and wounds allegedly created value for the charged referral network.
Referral illegality remains distinct from clinical fraud
The government advances several theories that may overlap factually but remain legally distinct, including unnecessary treatment, services never performed, false medical records, claims ineligible because of kickbacks, and remuneration exchanged for patient referrals.
A product could be clinically useful yet still create reimbursement exposure if procured through an unlawful referral payment, while a nonexistent application could constitute fraud without requiring proof that any patient source received money.
Similarly, poor documentation or disputed medical judgment does not automatically establish a kickback, and compensation alone does not prove that every associated treatment was unnecessary, fictitious, or knowingly misrepresented to the Medicare contractor.
Prosecutors allege Tesar and others fabricated prior conservative care, earlier wound documentation, patient conditions, and services purportedly performed, while also billing for some allograft applications that allegedly never occurred at all according to investigators.
The defense can force the government to separate those pathways patient by patient, insisting that questionable necessity does not prove non-performance, documentation errors do not establish willfulness, and ordinary compensation does not become criminal without prohibited purpose.
That analytical separation is especially important for Presha and Evans because the indictment does not charge either registered nurse with the five substantive health-care fraud executions brought against Tesar, although the conspiracy allegations encompass broader conduct.
Ten counts allocate different alleged responsibilities
Counts one through five accuse Tesar of health-care fraud and aiding or abetting specified executions involving five anonymized beneficiaries, whose listed claims collectively sought approximately $3.96 million and resulted in roughly $2.82 million in Medicare payments.
Count six charges all three defendants with conspiring to defraud the United States and to offer, pay, solicit, and receive kickbacks, creating the legal framework connecting the purported patient-sourcing relationships with Medicare’s administrative functions.
Counts seven and eight focus upon Tesar’s alleged role in causing the two Company One deposits, while count nine addresses Presha’s alleged receipt and count ten addresses Evans’s alleged receipt of remuneration for referrals.
The allocation means evidence of Tesar’s clinical decisions cannot substitute for proof that Presha or Evans knowingly joined an unlawful agreement, just as evidence about one recipient cannot automatically establish another’s culpability.
Jurors, if the case proceeds to trial, would be instructed to evaluate each count and each defendant separately under the applicable elements, rather than treating three nursing licenses, intertwined businesses, or shared communications as collective guilt.
Evidence must connect people, products, and payments
The prosecution can seek testimony from beneficiaries, caregivers, clinical employees, distributor personnel, and other providers, then compare those accounts with communications, contracts, product orders, medical records, invoices, claims, and associated bank activity records.
Electronic evidence may reveal when a representative first identified a patient, what clinical information was conveyed, who chose the product, whether consent and cost were explained, and how the resulting invoice was assigned for compensation.
Records from W P Enterprises and Healing His Way may show services, payroll, expenses, customers, and withdrawals, helping jurors decide whether the entities supported functioning sales businesses or primarily received money attributable to identified beneficiaries.
Clinical proof will remain essential because prosecutors have tied the alleged referral system to allografts described as unnecessary, infected, unsuccessful, or unperformed, while the defense can contest every patient-specific conclusion through records and qualified experts.
The government may also use comparative data to identify unusual concentrations in claim value, square-centimeter utilization, product choice, application frequency, and referral source, although an extreme statistical pattern cannot establish criminal intent without corroborating evidence.
Defense lawyers can challenge witness memory, message context, data selection, invoice attribution, corporate ownership, payment methodology, medical interpretation, and the possibility that legitimate care or work has been swept into an overstated aggregate theory.
Grand jury proceedings provide no public cross-examination or defense presentation, so the indictment offers a detailed accusation rather than a tested evidentiary record, and its factual claims may later be narrowed, disputed, dismissed, admitted, or rejected.
A national takedown amplified the local allegations
Regional coverage by WWSB summarized the charges against Tesar, Presha, and Evans while emphasizing the $118 million claim total, approximately $61 million paid, and roughly $11.8 million seized by federal authorities during the investigation.
The case was announced during the 2026 National Health Care Fraud Takedown, which charged 455 defendants across fifty-six federal districts and forty-five states and territories in alleged schemes involving more than $6.5 billion in claims.
Federal officials said ninety physicians and other licensed professionals were included nationwide, illustrating why allegations involving nurses can attract exceptional attention from patients, employers, regulators, payers, and professional communities before any courtroom resolution occurs.
Authorities reported more than $182 million in nationwide seizures, while the Tesar indictment separately seeks forfeiture figures attributed to each defendant, although restraint or seizure never establishes final ownership, traceability, criminal proceeds, or entitlement to forfeiture.
National enforcement statistics provide context rather than proof, because the Florida defendants must be judged exclusively through admissible evidence connected with their own alleged conduct, statutory elements, asserted defenses, and the reasonable-doubt standard.
Professional trust intensifies the public impact
Allegations that nurses acted as compensated patient sources can damage confidence beyond a single prosecution, because patients often rely upon nursing professionals for candid guidance when illness, age, mobility limits, or unfamiliar insurance rules reduce independent bargaining power.
Employers and compliance teams reviewing comparable relationships should assess whether outside compensation follows patient volume, product price, claim payment, or invoice value; document legitimate services; and separate clinical decisions from commercial rewards.
Useful controls can include conflict disclosures, fair-market-value review, written duties, exclusion screening, referral-independent compensation, patient cost explanations, medical-necessity audits, inventory reconciliation, and protected internal reporting channels for staff who observe pressure or irregularity.
Those safeguards do not presume wrongdoing by sales representatives or clinicians, but they help an organization explain why a payment occurred, what work supported it, who selected treatment, and whether patient welfare remained insulated from financial incentives.
The indictment’s alleged twenty-percent calculations and patient-linked payment assignments show the kind of compensation structure investigators may scrutinize when reimbursed product value rises dramatically with each referral and treatment decision inside clinics.
Public accusations demand measured communication
A prominently announced Medicare kickbacks case can affect professional licensing, payer enrollment, banking relationships, employees, patients, referral partners, and search results long before motions, testimony, expert review, or verdicts establish what actually occurred.
Organizations facing comparable scrutiny may need disciplined crisis public relations management that coordinates verified statements with counsel, preserves evidence, corrects demonstrable inaccuracies, respects court restrictions, and avoids declaring guilt or exoneration before adjudication.
Longer-term reputation rebuilding strategies can present accurate procedural updates, documented compliance improvements, verified credentials, and meaningful accountability without erasing legitimate journalism, manipulating public records, intimidating critics, or concealing information relevant to patients and regulators.
Nothing in the reviewed public materials indicates that Amicus International Consulting represents Tesar, Presha, Evans, Primecare, Company One, or any connected person or organization, and these observations concern only general communication challenges surrounding unresolved federal allegations.
Responsible coverage should preserve the difference between the indictment’s language and the headline’s “patient feeders” shorthand, while updating the public record if later proceedings produce dismissals, pleas, acquittals, convictions, sentences, restitution, or forfeiture decisions.
What the alleged patient pipeline still must prove
The prosecution’s central narrative presents a commercial cycle in which nurses allegedly found beneficiaries, Primecare furnished or claimed expensive allografts, Medicare paid submitted claims, and the distributor returned invoice-linked value to the people credited with referrals.
To secure convictions, prosecutors must prove more than the existence of introductions, treatment, large invoices, and payments, because each offense requires evidence connecting specified conduct with the legally required knowledge, purpose, and federal-program relationship.
Presha and Evans may argue that they performed legitimate services, identified appropriate patients, relied upon Tesar’s independent clinical judgment, or lacked knowledge that any claim, record, product choice, agreement, or payment was unlawful.
Tesar may contest the alleged referral bargain, medical-necessity conclusions, chart interpretations, payment characterization, ownership narrative, and aggregate financial calculations, while requiring the government to prove every charged execution and kickback beyond reasonable doubt.
Until that adversarial process is completed, the Leigh Tesar Medicare kickbacks case remains an unresolved federal prosecution whose “patient feeder” allegation must be treated as a contested theory, not a judicial finding about any defendant.
